Figure 3.
Figure 3. In vitro and in vivo ASC survival is dependent on CD138 expression. (A-D) Purified B cells from WT and sdc1-deficient mice (sdc1−/−) were cocultured in vitro with LPS for 3 days and ASC generation (YFP+) was examined. (A) Purified B cells from WT and sdc1−/− mice were pre-labeled with celltrace violet, and analyzed for cell division up to day 6 of culture. Resting B cells cultured in the absence of LPS were used as a control. (B) Flow cytometry gating strategy depicting a contour plot of YFP+ ASCs generated following culture. WT (blue) ASCs were distinguished from CD138-deficient ASCs (red) by the expression of CD45.1 using flow cytometry. (C) The percentage of YFP+ ASCs generated by in vitro culture is demonstrated on day 3 and day 6 and expressed as a percentage of total cells. (D) YFP+ ASCs derived from WT B cells were examined for apoptosis on day 3 after culture with LPS. Mature CD138+YFP+ ASCs were distinguished from immature CD138− ASCs by flow cytometry, and apoptosis was examined using Annexin V or activated caspase 3 staining. (E) Human PBMCs were examined by flow cytometry. Gating on CD19lowCD20−CD38high cells revealed CD138+ and CD138− fractions that were examined for Annexin V staining. Representative contour plots are demonstrated. (F-K) YFP+ ASCs were generated in vivo following co-transfer of purified naïve B cells from WT and sdc1−/− mice and immunization with NP-OVA (protocol depicted in Figure 2A). (F) Cells from the dLN of immunized mice were stained for Annexin V to examine apoptosis and analyzed by flow cytometry. The percentage of apoptosis in YFP+ ASCs or YFP− transferred cells is depicted (WT [blue]; sdc1−/− [red]). (G) Within the WT ASC compartment, mature CD138+YFP+ ASCs were distinguished from immature CD138− ASCs by flow cytometry. A representative dot plot is shown (left). The graph represents the percentage of cell apoptosis within the CD138+ and CD138− subsets in dLN of immunized mice (right). (H) Intravital two-photon microscopy was performed on the surgically exposed popliteal LNs of immunized mice. Myeloid cells (blue), ASCs (green), naive B cells (red), and collagen (purple) could be distinguished from one another. A representative image of an apoptotic event is depicted. Apoptotic events were recorded and quantified in a blinded manner (left). Graph represents the number of apoptotic events observed per hour (right). (I-J) Cells from the dLN of immunized mice were stained for Bcl-2 (I) or Mcl-1 (J), and analyzed by flow cytometry. Graph depicts MFI in YFP+ ASCs from either WT (blue) or sdc1−/−-derived (red) cells. Within the WT ASC compartment, mature CD138+YFP+ ASCs (open circles) were distinguished from immature CD138− ASCs (closed circles) by flow cytometry, and graph depicts MFI. FMO controls included. (K) dLN cells were stained with ki67 to examine proliferation by flow cytometry. WT YFP+ (red) and CD138-deficient YFP+ (blue) ASCs are depicted in a representative histogram. *P < .05; **P < .01; ***P < .001. dLN, draining lymph nodes; FMO, fluorescence minus one; ns, not significant; PBMCs, peripheral blood mononuclear cells.

In vitro and in vivo ASC survival is dependent on CD138 expression. (A-D) Purified B cells from WT and sdc1-deficient mice (sdc1−/−) were cocultured in vitro with LPS for 3 days and ASC generation (YFP+) was examined. (A) Purified B cells from WT and sdc1−/− mice were pre-labeled with celltrace violet, and analyzed for cell division up to day 6 of culture. Resting B cells cultured in the absence of LPS were used as a control. (B) Flow cytometry gating strategy depicting a contour plot of YFP+ ASCs generated following culture. WT (blue) ASCs were distinguished from CD138-deficient ASCs (red) by the expression of CD45.1 using flow cytometry. (C) The percentage of YFP+ ASCs generated by in vitro culture is demonstrated on day 3 and day 6 and expressed as a percentage of total cells. (D) YFP+ ASCs derived from WT B cells were examined for apoptosis on day 3 after culture with LPS. Mature CD138+YFP+ ASCs were distinguished from immature CD138 ASCs by flow cytometry, and apoptosis was examined using Annexin V or activated caspase 3 staining. (E) Human PBMCs were examined by flow cytometry. Gating on CD19lowCD20CD38high cells revealed CD138+ and CD138 fractions that were examined for Annexin V staining. Representative contour plots are demonstrated. (F-K) YFP+ ASCs were generated in vivo following co-transfer of purified naïve B cells from WT and sdc1−/− mice and immunization with NP-OVA (protocol depicted in Figure 2A). (F) Cells from the dLN of immunized mice were stained for Annexin V to examine apoptosis and analyzed by flow cytometry. The percentage of apoptosis in YFP+ ASCs or YFP transferred cells is depicted (WT [blue]; sdc1−/− [red]). (G) Within the WT ASC compartment, mature CD138+YFP+ ASCs were distinguished from immature CD138 ASCs by flow cytometry. A representative dot plot is shown (left). The graph represents the percentage of cell apoptosis within the CD138+ and CD138 subsets in dLN of immunized mice (right). (H) Intravital two-photon microscopy was performed on the surgically exposed popliteal LNs of immunized mice. Myeloid cells (blue), ASCs (green), naive B cells (red), and collagen (purple) could be distinguished from one another. A representative image of an apoptotic event is depicted. Apoptotic events were recorded and quantified in a blinded manner (left). Graph represents the number of apoptotic events observed per hour (right). (I-J) Cells from the dLN of immunized mice were stained for Bcl-2 (I) or Mcl-1 (J), and analyzed by flow cytometry. Graph depicts MFI in YFP+ ASCs from either WT (blue) or sdc1−/−-derived (red) cells. Within the WT ASC compartment, mature CD138+YFP+ ASCs (open circles) were distinguished from immature CD138 ASCs (closed circles) by flow cytometry, and graph depicts MFI. FMO controls included. (K) dLN cells were stained with ki67 to examine proliferation by flow cytometry. WT YFP+ (red) and CD138-deficient YFP+ (blue) ASCs are depicted in a representative histogram. *P < .05; **P < .01; ***P < .001. dLN, draining lymph nodes; FMO, fluorescence minus one; ns, not significant; PBMCs, peripheral blood mononuclear cells.

Close Modal

or Create an Account

Close Modal
Close Modal